SK287850B6 - Stable pharmaceutical form of the anti-cancer drug - Google Patents

Stable pharmaceutical form of the anti-cancer drug Download PDF

Info

Publication number
SK287850B6
SK287850B6 SK629-2003A SK6292003A SK287850B6 SK 287850 B6 SK287850 B6 SK 287850B6 SK 6292003 A SK6292003 A SK 6292003A SK 287850 B6 SK287850 B6 SK 287850B6
Authority
SK
Slovakia
Prior art keywords
paclitaxel
solvents
mixture
range
vials
Prior art date
Application number
SK629-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK6292003A3 (en
Inventor
Stanislaw Janicki (Zomrel)
Alicja Maria Janicka (Dedic)
Malgorzata Janicka-Kokitko (Dedic)
Malgorzata Sznitowska
Wladyslaw Karas
Zdislaw Mroczek
Andrzej Tyrala
Iwona Czarnecka
Original Assignee
Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna
Instytut Chemii Organicznej Pan
Akademia Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna, Instytut Chemii Organicznej Pan, Akademia Medyczna filed Critical Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna
Publication of SK6292003A3 publication Critical patent/SK6292003A3/sk
Publication of SK287850B6 publication Critical patent/SK287850B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK629-2003A 2000-10-31 2001-10-19 Stable pharmaceutical form of the anti-cancer drug SK287850B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL343615A PL203300B1 (pl) 2000-10-31 2000-10-31 Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
PCT/PL2001/000082 WO2002036582A1 (en) 2000-10-31 2001-10-19 Stable pharmaceutical form of an anticancer drug

Publications (2)

Publication Number Publication Date
SK6292003A3 SK6292003A3 (en) 2004-08-03
SK287850B6 true SK287850B6 (sk) 2012-01-04

Family

ID=20077651

Family Applications (1)

Application Number Title Priority Date Filing Date
SK629-2003A SK287850B6 (sk) 2000-10-31 2001-10-19 Stable pharmaceutical form of the anti-cancer drug

Country Status (14)

Country Link
EP (1) EP1363892B1 (cs)
AU (1) AU2002212863A1 (cs)
BG (1) BG65985B1 (cs)
CZ (1) CZ300836B6 (cs)
DE (1) DE60122384T2 (cs)
HU (1) HUP0303089A3 (cs)
LT (1) LT5069B (cs)
PL (1) PL203300B1 (cs)
RU (1) RU2236227C1 (cs)
SI (1) SI21138B (cs)
SK (1) SK287850B6 (cs)
UA (1) UA75620C2 (cs)
WO (1) WO2002036582A1 (cs)
ZA (1) ZA200303276B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005038A (es) * 2001-11-30 2004-08-11 Bristol Myers Squibb Co Solvatos de paclitaxel.
DK1694660T3 (da) 2003-12-12 2009-08-10 Biorganica Ltda Fremgangsmåde til fremstilling af vandfri og hydrerede aktive farmaceutiske bestanddele (API's); stabile farmaceutiske sammensætninger fremstillet af disse og anvendelser af disse sammensætninger
AR054215A1 (es) * 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
EP2146695A4 (en) * 2007-04-23 2010-05-19 Sun Pharmaceuticals Ind Ltd PHARMACEUTICAL COMPOSITIONS
RU2370258C2 (ru) * 2007-11-16 2009-10-20 Закрытое Акционерное Общество "Биокад" Фармацевтическая композиция для парентеральной доставки в форме лиофилизата и способ ее получения
CN110437179A (zh) * 2019-08-22 2019-11-12 江苏红豆杉药业有限公司 一种紫杉醇单晶晶体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
RU2136673C1 (ru) * 1992-12-24 1999-09-10 Бристоль-Мейерз Сквибб Компани Фосфонооксиметиловые эфиры таксановых производных, промежуточные соединения, противоопухолевая фармацевтическая композиция, способ ингибирования роста опухоли у млекопитающих
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
FR2729666A1 (fr) * 1995-01-25 1996-07-26 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable

Also Published As

Publication number Publication date
DE60122384D1 (de) 2006-09-28
AU2002212863A1 (en) 2002-05-15
HK1060733A1 (en) 2004-08-20
DE60122384T2 (de) 2007-08-16
WO2002036582A1 (en) 2002-05-10
LT2003031A (en) 2003-09-25
SI21138B (sl) 2006-10-31
SI21138A (sl) 2003-08-31
LT5069B (lt) 2003-11-25
CZ20031421A3 (cs) 2004-06-16
HUP0303089A3 (en) 2005-02-28
BG65985B1 (bg) 2010-08-31
EP1363892B1 (en) 2006-08-16
ZA200303276B (en) 2004-04-21
UA75620C2 (en) 2006-05-15
RU2236227C1 (ru) 2004-09-20
HUP0303089A2 (hu) 2003-12-29
EP1363892A1 (en) 2003-11-26
BG107764A (bg) 2004-07-30
CZ300836B6 (cs) 2009-08-19
PL203300B1 (pl) 2009-09-30
SK6292003A3 (en) 2004-08-03
PL343615A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
AU724842B2 (en) Taxane composition and method
CN1169525C (zh) 紫杉烷的药物制剂
KR20140067034A (ko) 카바지탁셀 제제와 이를 제조하는 방법
CZ284080B6 (cs) Injikovatelná kompozice obsahující deriváty skupiny taxanů
AU2010308497A1 (en) Docetaxel formulations with lipoic acid
EP2903435B1 (en) Non-aqueous taxane nanodispersion formulations and methods of using the same
AU702519B2 (en) Parenteral pharmaceutical compositions containing GF120918A
WO2013022969A1 (en) Docetaxel formulations with lipoic acid
SK287850B6 (sk) Stable pharmaceutical form of the anti-cancer drug
ES2344674B1 (es) Composicion farmaceutica inyectable de taxanos.
HK1060733B (en) Method for the production of a stable pharmaceutical form of paclitaxel
KR20080096829A (ko) 정맥내 항바이러스 치료
US20250319066A1 (en) Injectable dmt formulations
CZ200756A3 (cs) Dvousložková farmaceutická kompozice obsahující taxan
HK1210665B (en) Non-aqueous taxane nanodispersion formulations and methods of using the same
MXPA97002473A (en) Parenteral pharmaceutical compositions containing gf1209

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121019